Previous close | 89.60 |
Open | 89.60 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 140.00 |
Expiry date | 2024-05-17 |
Day's range | 89.60 - 89.60 |
Contract range | N/A |
Volume | |
Open interest | N/A |
First Quarter 2024 Financial Performance Review
Inspire (INSP) delivered earnings and revenue surprises of 46.03% and 1.47%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Inspire Reports Year-over-YearRevenue Growth of 28% in the First Quarter and Expects Profitability for the Full Year 2024 MINNEAPOLIS, May 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended March 31, 2024. Recent Business Highlights Generated reven